FDA Warning Letter — Genzyme Corporation

Case 690604 — FEI 1220423

The FDA took a Warning Letter action against Genzyme Corporation on January 15, 2025 (Framingham, MA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Genzyme Corporation
Date
January 15, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Framingham, MA (United States)